期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

肿瘤免疫治疗及其临床应用新进展 被引量：2

Recent Research Progresses in Cancer Immunotherapy and Its Clinical Applications
原文传递
导出
摘要 肿瘤免疫治疗是通过调节机体的免疫功能而达到杀灭肿瘤细胞的目的的一种治疗手段,现已成为肿瘤治疗的主要措施之一。对肿瘤免疫治疗的方法及临床应用情况进行综述,旨在为肿瘤的临床治疗提供新的思路。 Cancer immunotherapy is a kind of therapeutic means through which tumor cells can be controlled and killed by regulating the immune function. It has become one of the main measures for cancer therapy. The recent progresses in the methods of cancer immunotherapy and its clinical applications has been reviewed in this paper, in order to provide new thoughts for the clinical treatment of cancer
作者 李娴静 吴红茜 杨勇 陈真
机构地区 中国药科大学药理学教研室 中国药科大学药物科学研究院
出处 《药学进展》 CAS 2013年第9期433-440,共8页 Progress in Pharmaceutical Sciences
基金 国家自然科学基金资助项目(No.91129731) 中央高校基本科研业务费专项资金资助项目(No.JKY2011084)
关键词 抗肿瘤 肿瘤免疫疗法 临床应用 anticancer cancer immunotherapy clinical application
分类号 R730.5 [医药卫生—肿瘤]
  • 相关文献

参考文献45

  • 1Kirkwood J M, Butterfield L H,Tarhini A A, et al. Immu- notherapy of cancer in 2012 [ J ]. CA Cancer J Clin,2012, 62(5) :309-335.
  • 2Anastasiadis A, de Reijke T M. Best practice in the treat- ment of nonmuscle invasive bladder cancer [ J ]. Ther Adv Uro1,2012,4 ( 1 ) : 13-32.
  • 3Kirkwood J. Cancer immunotherapy : the interferon-a expe- rience [ J ]. Semin Oncol, 2002,29 ( 3 ) : 18-26.
  • 4Dillman R O. The clinical experience with interleukin-2 in cancer therapy [ J ]. Cancer Biother, 1994,9 ( 3 ) : 183-209.
  • 5Weiner L M, Murray J C, Shuptrine C W. Antibody-based immunotherapy of cancer [ J ]. Cell, 2012, 148 ( 6 ) : 1081-1084.
  • 6Mellman I, Coukos G, Dranoff G. Cancer immunotherapy comes of age [ J ]. Nature ,2011,480 ( 7378 ) :480-489.
  • 7Trombetta E S,Mellman I. Cell biology of antigen proces- sing in vitro and in vivo [ J ]. Annu Rev Immunol , 2005, 23 : 975-1028.
  • 8Zitvogel L, Kroemer G. Anticancer immunochemothera-py using adjuvants with direct cytotoxic effects[ J ]. J Clin Invest,2009,119(8) :2127-2130 .
  • 9Palucka K, Banchereau J, Mellman I. Designing vaccines based on biology of human dendritic cell subsets [ J ]. Immunity, 201 O, 33 ( 4 ) : 464 - 478.
  • 10Darrasse-Jeze G, Deroubaix S, Mouquet H, et al. Feedback control of regulatory T cell homeostasis by dendritic cells in vivo[ J ]. J Exp Med,2009 ,206( 9 ) : 1853-1862.

二级参考文献24

  • 1张建国,王艳丽,李静,孙宗立,周四维.生物治疗预防肾癌根治术后复发和转移的远期疗效观察[J].中国医师杂志,2005,7(10):1309-1311. 被引量：7
  • 2Jemal A,Siegel R,Ward E,et al.Cancer statistics,2009[J].CA Cancer J Clin,2009,59(4):225-249.
  • 3Yagoda A,Abi-Rached B,Petrylak D.Chemotherapy for advanced renal-cell carcinoma:1983-1993[J].Semin Oncol,1995,22(1):42-60.
  • 4Belldegrun AS,Klatte T,Shuch B,et al.Cancer-specific survival outcomes among patients treated during the cytokine era of kidney cancer (1989-2005):a benchmark for emerging targeted cancer therapies[J].Cancer,2008,113(9):2457-2463.
  • 5Pizzocaro G,Piva L,Colavita M,et al.Interferon adjuvant to radical nephrectomy in Robson stages II and III renal cell carcinoma:a multicentric randomized study[J].J Clin Oncol,2001,19(2):425-431.
  • 6Basting R,Corvin S,Handel D,et al.Adjuvant immunotherapy in renal cell carcinoma-comparison of interferon alpha treatment with an untreated control[J].Anticancer Res,1999,19(2C):1545-1548.
  • 7Galligioni E,Quaia M,Merlo A,et al.Adjuvant immunotherapy treatment of renal carcinoma patients with autologous tumor cells and bacillus Calmette-Guerin:five-year results of a prospective ran-domized study[J].Cancer,1996,77(12):2560-2566.
  • 8Messing EM,Manola J,Wilding G,et al.Phase III study of interferon alfa-NL as adjuvant treatment for resectable renal cell carcinoma:an Eastern Cooperative Oncology Group/Intergroup trial[J].J Clin Oncol,2003,21(7):1214-1222.
  • 9Basting R,Corvin S,Handel D,et al.Adjuvant interferon alpha therapy in renal cell carcinoma (RCC):prognostic value of DNA cytophotometry[J].Anticancer Res,1999,19(2C):1493-1495.
  • 10Kai F,Takayama T,Sugiyama T,et al.Efficacy of adjuvant inter-feron-alpha therapy following curative resection in renal cell carci-noma:before the molecular targeting therapy era[J].Jpn J Clin Oncol,2009,39(5):310-314.

共引文献16

同被引文献14

引证文献2

二级引证文献2

药学进展
2013年 第9期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部